These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26221486)

  • 21. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
    Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
    J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells.
    Nan B; Yang H; Yan S; Lin PH; Lumsden AB; Yao Q; Chen C
    Surgery; 2005 Aug; 138(2):212-22. PubMed ID: 16153429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression?
    Khorramdelazad H; Bagheri V; Hassanshahi G; Karami H; Moogooei M; Zeinali M; Abedinzadeh M
    Asian Pac J Cancer Prev; 2015; 16(7):2725-9. PubMed ID: 25854354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
    Oesterle A; Bowman MA
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment.
    Gorska-Ciebiada M; Saryusz-Wolska M; Borkowska A; Ciebiada M; Loba J
    Front Aging Neurosci; 2015; 7():209. PubMed ID: 26578953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
    Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial infarction.
    Wang C; Li H; Fu P; Zhang S; Xiu R
    Clin Hemorheol Microcirc; 2005; 32(4):287-96. PubMed ID: 15894827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activation of receptor for advanced glycation end products: a mechanism for monocyte-mediated inflammation in chronic renal failure].
    Hou FF; Ren H; Guo ZJ; Chen PY; Liang M; Zhang X
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1614-9. PubMed ID: 15569456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products influence mitochondrial fusion-fission dynamics through RAGE in human aortic endothelial cells.
    Zhang S; Gao Y; Wang J
    Int J Clin Exp Pathol; 2017; 10(7):8010-8022. PubMed ID: 31966653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end-products increase IL-6 and ICAM-1 expression via RAGE, MAPK and NF-κB pathways in human gingival fibroblasts.
    Nonaka K; Kajiura Y; Bando M; Sakamoto E; Inagaki Y; Lew JH; Naruishi K; Ikuta T; Yoshida K; Kobayashi T; Yoshie H; Nagata T; Kido J
    J Periodontal Res; 2018 Jun; 53(3):334-344. PubMed ID: 29193068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
    Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
    FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A12 inhibits fibroblast migration via the receptor for advanced glycation end products and p38 MAPK signaling.
    Tanaka N; Ikari J; Anazawa R; Suzuki M; Katsumata Y; Shimada A; Suzuki E; Matsuura Y; Kawata N; Tada Y; Tatsumi K
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):656-664. PubMed ID: 31297698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.
    Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    Perit Dial Int; 2016; 36(3):269-76. PubMed ID: 26493750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of Transient Receptor Potential Channel 4 Alleviates oxLDL-induced Angiogenesis in Human Coronary Artery Endothelial Cells by Inhibition of VEGF and NF-κB.
    Qin W; Xie W; Xia N; He Q; Sun T
    Med Sci Monit; 2016 Mar; 22():930-6. PubMed ID: 26999308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis.
    Cai XG; Xia JR; Li WD; Lu FL; Liu J; Lu Q; Zhi H
    Mol Med Rep; 2014 Jul; 10(1):306-14. PubMed ID: 24804792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
    Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
    Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.